US 11,124,490 B2Granted

Autotaxin inhibitors

AssigneesUniversity of Tennessee Research Foundation, The University of Memphis

InventorsDuane D. Miller, Gabor G. Tigyi, Souvik Banerjee, Abby L. Parrill-Baker

Life of this patent

Estimating the term…

Abstract

The present disclosure provides novel ATX inhibitors, and pharmaceutical compositions comprising said inhibitors, as well as methods of treatment comprising administration of said inhibitors.

Claims1

Dependent claims

A compound having the structure:

Dependencies are inferred from the claim text.

Facts

Application: 16/305,345Filed 2 Jun 2017 · us provisional application
Priority: 3 Jun 2016
Published: US 2020/0317626 A18 Oct 2020
Granted: 21 Sep 2021
Term ends: Not estimatedThe source records don’t support an estimate.

Classification14 codes

A61K 31/495
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with two or more nitrogen atoms as the only ring…
C07D 265/30
1,4-Oxazines; Hydrogenated 1,4-oxazines: not condensed with other rings
A61K 31/10
Sulfur, selenium, or tellurium compounds, e.g. thiols: sulfides; Sulfoxides; Sulfones
A61K 31/18
Amides, e.g. hydroxamic acids: sulfonamides

Family

Application62/345,472Us provisional application · filed 3 Jun 2016
US 2020/0317626 A1Pre-grant publication · published 8 Oct 2020
US 11,124,490 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…